Clinical Trials

NCT05092451 | RECRUITING | PHASE1/PHASE2
80 participants

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2022-11-01
Completion:
2030-08-31
Conditions
  • B-Cell Lymphoma
  • Myelodysplastic Syndromes (MDS)
  • Acute Myeloid Leukemia (AML)
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Hodgkin Lymphoma
  • T-cell Non-Hodgkin's Lymphoma/ T-cell Acute Lymphoblastic Leukmeia
  • Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia
  • Blastic Transformation of Chronic Myeloid Leukemia
  • Germ Cell Tumors
Interventions
  • DRUG
No Results Yet
NCT05020444 | ACTIVE_NOT_RECRUITING | PHASE1
16 participants

TriPRIL CAR T Cells in Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2021-10-05
Completion:
2028-02-24
Conditions
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Refractory Multiple Myeloma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page